Cetuximab
Cetuximab market is segmented by region (country), players, by Type and by Application. Players, ... Read More
Global and United States Bevacizumab Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Bevacizumab Product Introduction
1.2 Global Bevacizumab Outlook 2017 VS 2022 VS 2028
1.2.1 Global Bevacizumab Sales in US$ Million for the Year 2017-2028
1.2.2 Global Bevacizumab Sales in Volume for the Year 2017-2028
1.3 United States Bevacizumab Outlook 2017 VS 2022 VS 2028
1.3.1 United States Bevacizumab Sales in US$ Million for the Year 2017-2028
1.3.2 United States Bevacizumab Sales in Volume for the Year 2017-2028
1.4 Bevacizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Bevacizumab in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Bevacizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Bevacizumab Market Dynamics
1.5.1 Bevacizumab Industry Trends
1.5.2 Bevacizumab Market Drivers
1.5.3 Bevacizumab Market Challenges
1.5.4 Bevacizumab Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Bevacizumab Market Segment by Type
2.1.1 Avastin (bevacizumab)
2.1.2 Mvasi (bevacizumab-awwb)
2.2 Global Bevacizumab Market Size by Type
2.2.1 Global Bevacizumab Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Bevacizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Bevacizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Bevacizumab Market Size by Type
2.3.1 United States Bevacizumab Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Bevacizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Bevacizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Bevacizumab Market Segment by Application
3.1.1 Cancer
3.1.2 Eye Diease
3.2 Global Bevacizumab Market Size by Application
3.2.1 Global Bevacizumab Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Bevacizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Bevacizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Bevacizumab Market Size by Application
3.3.1 United States Bevacizumab Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Bevacizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Bevacizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Bevacizumab Competitor Landscape by Company
4.1 Global Bevacizumab Market Size by Company
4.1.1 Top Global Bevacizumab Manufacturers Ranked by Revenue (2021)
4.1.2 Global Bevacizumab Revenue by Manufacturer (2017-2022)
4.1.3 Global Bevacizumab Sales by Manufacturer (2017-2022)
4.1.4 Global Bevacizumab Price by Manufacturer (2017-2022)
4.2 Global Bevacizumab Concentration Ratio (CR)
4.2.1 Bevacizumab Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Bevacizumab in 2021
4.2.3 Global Bevacizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Bevacizumab Manufacturing Base Distribution, Product Type
4.3.1 Global Bevacizumab Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Bevacizumab Product Type
4.3.3 Date of International Manufacturers Enter into Bevacizumab Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Bevacizumab Market Size by Company
4.5.1 Top Bevacizumab Players in United States, Ranked by Revenue (2021)
4.5.2 United States Bevacizumab Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Bevacizumab Sales by Players (2020, 2021 & 2022)
5 Global Bevacizumab Market Size by Region
5.1 Global Bevacizumab Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Bevacizumab Market Size in Volume by Region (2017-2028)
5.2.1 Global Bevacizumab Sales in Volume by Region: 2017-2022
5.2.2 Global Bevacizumab Sales in Volume Forecast by Region (2023-2028)
5.3 Global Bevacizumab Market Size in Value by Region (2017-2028)
5.3.1 Global Bevacizumab Sales in Value by Region: 2017-2022
5.3.2 Global Bevacizumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Bevacizumab Market Size YoY Growth 2017-2028
6.1.2 North America Bevacizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Bevacizumab Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Bevacizumab Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Bevacizumab Market Size YoY Growth 2017-2028
6.3.2 Europe Bevacizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Bevacizumab Market Size YoY Growth 2017-2028
6.4.2 Latin America Bevacizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Bevacizumab Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Bevacizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Genentech
7.1.1 Genentech Corporation Information
7.1.2 Genentech Description and Business Overview
7.1.3 Genentech Bevacizumab Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Genentech Bevacizumab Products Offered
7.1.5 Genentech Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Bevacizumab Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Bevacizumab Products Offered
7.2.5 Amgen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Bevacizumab Industry Chain Analysis
8.2 Bevacizumab Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Bevacizumab Distributors
8.3 Bevacizumab Production Mode & Process
8.4 Bevacizumab Sales and Marketing
8.4.1 Bevacizumab Sales Channels
8.4.2 Bevacizumab Distributors
8.5 Bevacizumab Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Bevacizumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Bevacizumab Market Trends
Table 3. Bevacizumab Market Drivers
Table 4. Bevacizumab Market Challenges
Table 5. Bevacizumab Market Restraints
Table 6. Global Bevacizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Bevacizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Bevacizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Bevacizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Bevacizumab Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Bevacizumab Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Bevacizumab Revenue Share by Manufacturer, 2017-2022
Table 13. Global Bevacizumab Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Bevacizumab Sales Share by Manufacturer, 2017-2022
Table 15. Global Bevacizumab Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Bevacizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Bevacizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bevacizumab as of 2021)
Table 18. Top Players of Bevacizumab in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Bevacizumab Product Type
Table 20. Date of International Manufacturers Enter into Bevacizumab Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Bevacizumab Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Bevacizumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Bevacizumab Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Bevacizumab Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Bevacizumab Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Bevacizumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Bevacizumab Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Bevacizumab Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Bevacizumab Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Bevacizumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Bevacizumab Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Bevacizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Bevacizumab Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Bevacizumab Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Bevacizumab Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Bevacizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Bevacizumab Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Bevacizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Bevacizumab Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Bevacizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Genentech Corporation Information
Table 43. Genentech Description and Business Overview
Table 44. Genentech Bevacizumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Genentech Bevacizumab Product
Table 46. Genentech Recent Development
Table 47. Amgen Corporation Information
Table 48. Amgen Description and Business Overview
Table 49. Amgen Bevacizumab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Amgen Product
Table 51. Amgen Recent Development
Table 52. Key Raw Materials Lists
Table 53. Raw Materials Key Suppliers Lists
Table 54. Bevacizumab Customers List
Table 55. Bevacizumab Distributors List
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Bevacizumab Product Picture
Figure 2. Global Bevacizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Bevacizumab Market Size 2017-2028 (US$ Million)
Figure 4. Global Bevacizumab Sales 2017-2028 (K Units)
Figure 5. United States Bevacizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Bevacizumab Market Size 2017-2028 (US$ Million)
Figure 7. United States Bevacizumab Sales 2017-2028 (K Units)
Figure 8. United States Bevacizumab Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Bevacizumab Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Bevacizumab Report Years Considered
Figure 11. Product Picture of Avastin (bevacizumab)
Figure 12. Product Picture of Mvasi (bevacizumab-awwb)
Figure 13. Global Bevacizumab Market Share by Type in 2022 & 2028
Figure 14. Global Bevacizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Bevacizumab Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Bevacizumab Sales by Type (2017-2028) & (K Units)
Figure 17. Global Bevacizumab Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Bevacizumab Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Bevacizumab Market Share by Type in 2022 & 2028
Figure 20. United States Bevacizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Bevacizumab Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Bevacizumab Sales by Type (2017-2028) & (K Units)
Figure 23. United States Bevacizumab Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Bevacizumab Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Cancer
Figure 26. Product Picture of Eye Diease
Figure 27. Global Bevacizumab Market Share by Application in 2022 & 2028
Figure 28. Global Bevacizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Bevacizumab Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Bevacizumab Sales by Application (2017-2028) & (K Units)
Figure 31. Global Bevacizumab Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Bevacizumab Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States Bevacizumab Market Share by Application in 2022 & 2028
Figure 34. United States Bevacizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Bevacizumab Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Bevacizumab Sales by Application (2017-2028) & (K Units)
Figure 37. United States Bevacizumab Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Bevacizumab Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Bevacizumab Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America Bevacizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Bevacizumab Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe Bevacizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Bevacizumab Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific Bevacizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Bevacizumab Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Bevacizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Bevacizumab Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Bevacizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Bevacizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Bevacizumab Value Chain
Figure 73. Bevacizumab Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genentech Amgen